Boehringer Ingelheim Pharma GmbH & Co.KG - Germany
| Държава: | Германия |
| Кратка информация: | The history of Boehringer Ingelheim: A tradition of innovation The pharmaceutical company Boehringer Ingelheim was founded in 1885 by Albert Boehringer (1861-1939) in Ingelheim am Rhein. The pharmaceutical company Boehringer Ingelheim was founded in 1885 by Albert Boehringer (1861-1939) in Ingelheim am Rhein. From its beginnings in 1885 when it employed just 28 people in Nieder-Ingelheim, the company has since become a global enterprise. As part of research and development activities for innovative drugs, the company focuses primarily on the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. Historical timeline of Boehringer Ingelheim Production of lactic acid begins. 1885 – 1948: Innovative beginnings In 1885, Albert Boehringer purchased a small tartar factory in the Rhine-Hessian village of Nieder-Ingelheim. On 31 July, his company was included in the commercial register as “Albert Böhringer, chem. Fabrik vom 1. Aug. 1885 ab”. This laid the foundation for the present-day company Boehringer Ingelheim. He initially employed 28 people to manufacture tartaric acid salts used by pharmacies and dyeing works. Demand for this product surged in the first few years as fizzy lemonade and baking powder became popular. In 1893, Boehringer made the ground-breaking discovery that lactic acid can be produced in mass quantities by means of bacteria, a discovery that saw the company pioneer large-scale "biotech" production. Boehringer Ingelheim Pharmaceuticals, Inc. in Ridgefield 1948 – 1988: Going global Following the death of Albert Boehringer (1861 - 1939), his two sons Albert jr. (1891-1960) and Ernst Boehringer (1896-1965) as well as his son-in-law Julius Liebrecht (1891-1974) took over this family company. They recognised the importance of international markets for chemical-pharmaceutical companies. A home-based subsidiary was established in 1946 in Biberach an der Riss when the Thomae production unit was added to Boehringer Ingelheim’s two existing plants. The first foreign subsidiary, which was established in Vienna in 1948, was followed by more subsidiaries in Europe and overseas. Value through Innovation 1988 – 2010: Value through innovation Following the death of Hubertus Liebrecht (1991), the owning family made some fundamental decisions regarding the company’s alignment. This was in response to changing global healthcare standards and the increasing cost of healthcare, and was designed to maintain the company’s leading position as a research-based pharmaceutical company. The corporate vision "Value through Innovation” is promoted and becomes firmly rooted in the company. This vision defines the targets and framework for the future of the company and represents the global leitmotif and orientation framework. |
| Сайт: | http://www.boehringer-ingelheim.com |
